Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk of stroke in clopidogrel non-responders
2011-004748-23Phase 4Terminated
- Sponsor
- Neurologisk Afdeling
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of clopidogrel in ischemic stroke, sponsored by Neurologisk Afdeling. Primary endpoints: vascular death, risk of apoplexia cerebri in clopidogrel non-responders and 1 more. Started Oct 2011; status: terminated.
02
Drugs
clopidogrel
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2011-004748-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004748-23.